Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis

OBJECTIVE: In 2008, the Thai government introduced the ‘high-cost medicines E2 access program’ as a part of the National List of Essential Medicines to increase patient access to medicines, improve clinical outcomes and make medicines more affordable. Our objective was to examine whether the ‘high-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sruamsiri, Rosarin, Wagner, Anita K, Ross-Degnan, Dennis, Lu, Christine Y, Dhippayom, Teerapon, Ngorsuraches, Surachat, Chaiyakunapruk, Nathorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800146/
https://www.ncbi.nlm.nih.gov/pubmed/26988346
http://dx.doi.org/10.1136/bmjopen-2015-008671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800146/
https://www.ncbi.nlm.nih.gov/pubmed/26988346
http://dx.doi.org/10.1136/bmjopen-2015-008671

Ejemplares similares